BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30401890)

  • 1. Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study.
    Singh D; Miettinen J; Duffy S; Malila N; Pitkäniemi J; Anttila A
    Br J Cancer; 2018 Nov; 119(11):1428-1435. PubMed ID: 30401890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
    Singh D; Malila N; Pitkäniemi J; Anttila A
    Int J Cancer; 2019 Jun; 144(12):2928-2935. PubMed ID: 30511466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of symptoms and breast cancer in population-based mammography screening in Finland.
    Singh D; Malila N; Pokhrel A; Anttila A
    Int J Cancer; 2015 Mar; 136(6):E630-7. PubMed ID: 25160029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
    Sankatsing VDV; Fracheboud J; de Munck L; Broeders MJM; van Ravesteyn NT; Heijnsdijk EAM; Verbeek ALM; Otten JDM; Pijnappel RM; Siesling S; de Koning HJ;
    BMC Cancer; 2018 Mar; 18(1):256. PubMed ID: 29506487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
    Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
    Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of reported symptoms in a breast screening programme.
    Williams RS; Brook D; Monypenny IJ; Gower-Thomas K
    Clin Radiol; 2002 Aug; 57(8):725-9. PubMed ID: 12169283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status.
    Kavanagh AM; Giles GG; Mitchell H; Cawson JN
    J Med Screen; 2000; 7(2):105-10. PubMed ID: 11002452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.
    Singh D; Pitkäniemi J; Malila N; Anttila A
    Breast Cancer Res Treat; 2016 Sep; 159(2):305-13. PubMed ID: 27496148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening and risk of breast cancer death: a population-based case-control study.
    Otto SJ; Fracheboud J; Verbeek AL; Boer R; Reijerink-Verheij JC; Otten JD; Broeders MJ; de Koning HJ;
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):66-73. PubMed ID: 22147362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.